What is a plasma cell neoplasm?

A plasma cell neoplasm occurs when abnormal plasma cells form cancerous tumors in bone or soft tissue. Multiple myeloma is one type of plasma cell neoplasm.

Plasma cells are white blood cells. They live mostly in bone marrow, the soft tissue inside bones. Their job is to make antibodies, the proteins that fight germs. Each healthy plasma cell makes a slightly different antibody. In a plasma cell neoplasm, one plasma cell copies itself again and again. The body then holds a large group of identical cells, all making the same antibody. Doctors call that single antibody a monoclonal protein, or M protein. Blood and urine tests can spot it, and that is often the first clue.

Plasma cell neoplasms are grouped by how many tumors are present. When there is only one tumor, the disease is called a plasmacytoma. When there are multiple tumors, it is called multiple myeloma. A plasmacytoma may sit inside a bone or in soft tissue outside bone. The soft tissue kind shows up most often in the tonsils, the back of the nose, or the sinuses.

There is also a stage that comes before cancer, and it is common. It is called MGUS, short for monoclonal gammopathy of undetermined significance. In MGUS, an M protein is present, plasma cells make up fewer than 10% of the bone marrow, and no organ is being harmed. MGUS is not cancer. NCI reports that myeloma, another plasma cell disorder, or lymphoma develops in 12% of people with MGUS by 10 years and 25% by 20 years, so most people who have it never develop cancer. The next step up is smoldering myeloma. There, plasma cells fill 10% to 60% of the marrow, or the M protein reaches 30 g/L (3 g/dL), but organs are still unharmed. Smoldering myeloma is usually watched closely rather than treated right away.

Myeloma is called active once it starts to damage the body. Doctors use a checklist known by the letters CRAB. C is calcium more than 1 mg/dL above the normal range. R is kidney trouble, meaning creatinine above 2 mg/dL or creatinine clearance under 40 mL/min. A is anemia, with hemoglobin below 10.0 g/dL. B is one or more holes in bone seen on a scan. Any single one of these calls for treatment. Three other findings also count: plasma cells at 60% or more of the marrow, a blood free light chain ratio of 100 or higher, or more than one focal spot of at least 5 mm on MRI.

The workup follows a set order. Serum protein electrophoresis and immunofixation sort out which M protein is present. A free light chain assay measures antibody fragments in the blood. A 24-hour urine test looks for the same proteins. A bone marrow biopsy counts plasma cells and checks their chromosomes. Imaging maps any bone damage, using plain X-rays, spinal MRI, or PET-CT.

The label matters because it sets the plan. Ask your team which term fits your case, and whether treatment starts now or later. If the plan is watching, ask how often you will be rechecked and which blood test they follow. Some warning signs need same-day care: sudden severe back pain, new leg weakness, loss of bladder control, or heavy thirst with confusion. Those can mean a spine bone is pressing on nerves, or that calcium has climbed too high.